US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Agree

65.59

-0.2300-0.35%

Volume:132.78K

Turnover:8.73M

Market Cap:8.16B

PE:35.42

High:66.07

Open:65.93

Low:65.58

Close:65.82

52wk High:82.08

52wk Low:64.43

Shares:124.38M

Float Shares:122.18M

Volume Ratio:0.19

T/O Rate:0.11%

Dividend:3.14

Dividend Rate:4.79%

EPS(TTM):1.85

EPS(LYR):1.77

ROE:3.70%

ROA:2.40%

PB:1.29

PE(LYR):37.06

Loading ...

Overview Company News Filings

Press Release: Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones

Agree Realty (ADC) Lifts Dividend As Income Narrative Keeps Valuation In Focus

Simply Wall St.

New Approval in China for Enhertu, a Key Antibody-Drug Conjugate from Daiichi Sankyo and AstraZeneca

Press Release: ArriVent BioPharma Reports Second Quarter 2026 Financial Results

Agree Realty Umumkan Dividen Bulanan USD 0,27 Per Saham##

Agree Realty Declares Monthly Common and Preferred Dividends

THOMSON REUTERS

Agree Realty Corporation - Declares Monthly Cash Dividend of $0.27 Per Common Share

THOMSON REUTERS

Philips, Exor Agree to Raise Stakeholding Cap to 22%

MT Newswires Live

BEONE MEDICINES Plans to Unveil Preliminary CEA ADC Findings for Non-Small Cell Lung Cancer, Including Both Squamous and Non-Squamous Cases

Press Release: OmniAb Reports Second Quarter 2026 Financial Results and Business Highlights

Press Release: NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results

Whitehawk’s HWK-016 ADC Trial Advances in Tough Ovarian and Endometrial Cancers

Is Sichuan Kelun Biotech Biopharmaceutical (SEHK:6990) Cheap As ADC Pipeline News Builds?

Simply Wall St.

Press Release: Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Press Release: Zai Lab Announces Second Quarter 2026 Financial Results and Recent Corporate Updates

Hong Kong Stock Moves: SKB BIO Surges Over 4% Before Noon as New Dual-Load ADC Drug Gets Clinical Trial Approval

Agree Realty Releases Transcript of Q2 2026 Earnings Call

Akari Therapeutics Releases CEO Corner Highlighting Strategic WhiteHawk Collaboration and the Expanding Opportunity for Dual-Payload ADC Innovation

Yomiuri: Japan, Mexico Agree to Expand Bilateral Cooperation on Economic Security, Energy

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/ADC/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ADC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADC\",,,,,undefined,":{"symbol":"ADC","market":"US","secType":"STK","nameCN":"Agree","latestPrice":65.59,"timestamp":1791561791080,"preClose":65.82,"halted":0,"volume":132777,"delay":0,"changeRate":-0.0034943786083255816,"floatShares":122178283,"shares":124379300,"eps":1.85165,"marketStatus":"Trading","change":-0.23,"latestTime":"10-09 12:03:11 EDT","open":65.93,"high":66.07,"low":65.58,"amount":8729638.963739999,"amplitude":0.007445,"askPrice":65.61,"askSize":23,"bidPrice":65.58,"bidSize":20,"shortable":3,"etf":0,"ttmEps":1.85165,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":766296000000,"exchange":"NYSE","adjPreClose":65.82,"dividendRate":0.047888,"preHourTrading":{"tag":"盘前","latestPrice":65.2693,"preClose":65.82,"latestTime":"08:01 EDT","volume":35,"amount":2291.21935,"timestamp":1791547304818,"change":-0.5507,"changeRate":-0.008367,"amplitude":0.053775},"postHourTrading":{"tag":"盘后","latestPrice":65.77,"preClose":65.82,"latestTime":"19:46 EDT","volume":18479,"amount":1216359.929,"timestamp":1791503209091,"change":-0.05,"changeRate":-0.00076,"amplitude":0.00076},"volumeRatio":0.186447,"impliedVol":0.265,"impliedVolPercentile":0.8884},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADC\",,,,,undefined,":{"symbol":"ADC","floatShares":122178283,"roa":"2.40%","roe":"3.70%","lyrEps":1.77,"volumeRatio":0.186447,"shares":124379300,"dividePrice":3.141,"high":66.07,"amplitude":0.007445,"preClose":65.82,"low":65.58,"week52Low":64.43,"pbRate":"1.29","psRate":"10.46","week52High":82.08,"institutionHeld":0.85,"latestPrice":65.59,"committee":-0.069767,"eps":1.85165,"divideRate":0.047888,"volume":132777,"delay":0,"ttmEps":1.85165,"open":65.93,"prevYearClose":72.03,"prevWeekClose":65.88,"prevMonthClose":66.81,"prevQuarterClose":66.81,"fiveDayClose":65.88,"twentyDayClose":71.23,"sixtyDayClose":80.75,"earningDate":1792425600000,"earningTime":"盘后","dividendPayoutRate":1.7363850728368737,"dividendFrequency":"M","dividendGrowthYears":10,"dividendGrowthRate":0.026999999999999986,"fiveYearAvgDividendRate":0.041531731300358074},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADC\",params:#limit:5,,,undefined,":[{"date":"2026-10-20","symbol":"ADC","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2026/09","expectedEps":1.11,"defaultRemindTime":1792526400000,"name":null,"time":"Post-Mkt","dateTimestamp":1792468800000,"actualEps":null},{"date":"2026-09-30","symbol":"ADC","amount":0.267,"announcedDate":"2026-09-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-30","defaultRemindTime":1790775000000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-14","payableDate":"2026-09-30","currency":"USD","dateTimestamp":1790740800000,"payDate":"2026-10-14"},{"date":"2026-08-31","symbol":"ADC","amount":0.267,"announcedDate":"2026-08-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-31","defaultRemindTime":1788183000000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-15","payableDate":"2026-08-31","currency":"USD","dateTimestamp":1788148800000,"payDate":"2026-09-15"},{"date":"2026-07-31","symbol":"ADC","amount":0.267,"announcedDate":"2026-07-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-31","defaultRemindTime":1785504600000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-14","payableDate":"2026-07-31","currency":"USD","dateTimestamp":1785470400000,"payDate":"2026-08-14"},{"date":"2026-07-30","symbol":"ADC","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2026/06","expectedEps":1.11,"defaultRemindTime":1785441600000,"name":null,"time":"Post-Mkt","dateTimestamp":1785384000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADC\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2017-01-03","value":0.495,"currency":"USD"},{"executeDate":"2017-03-29","recordDate":"2017-03-31","paymentDate":"2017-04-14","value":0.495,"currency":"USD"},{"executeDate":"2017-06-28","recordDate":"2017-06-30","paymentDate":"2017-07-14","value":0.505,"currency":"USD"},{"executeDate":"2017-09-28","recordDate":"2017-09-29","paymentDate":"2017-10-13","value":0.505,"currency":"USD"},{"executeDate":"2017-12-19","recordDate":"2017-12-20","paymentDate":"2018-01-03","value":0.52,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2381,"buy":0.381,"hold":0.381,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.381,"analysts":21,"updateTime":1784088000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADC","date":"2026-10-08","current":35.422461,"percent":0.134584,"low":31.539495,"twenty":37.342503,"median":41.115788,"eighty":43.476137,"high":50.705944,"avg":40.576349,"sd":3.647722,"marketCap":8092370919},"quantilePoints":[{"date":"2021-10-15","current":49.02563,"twenty":31.977009,"median":39.430911,"eighty":45.094688,"marketCap":4772841185},{"date":"2021-10-22","current":49.5269,"twenty":31.977009,"median":39.430911,"eighty":45.190701,"marketCap":4821641836},{"date":"2021-10-29","current":50.169373,"twenty":32.013133,"median":39.571166,"eighty":45.28245,"marketCap":4884189150},{"date":"2021-11-05","current":43.773853,"twenty":32.013133,"median":39.651928,"eighty":45.28245,"marketCap":4934976633},{"date":"2021-11-12","current":43.137928,"twenty":32.029424,"median":39.72736,"eighty":45.28245,"marketCap":4863283742},{"date":"2021-11-19","current":43.008274,"twenty":32.198132,"median":39.802558,"eighty":45.28245,"marketCap":4848666745},{"date":"2021-11-26","current":42.662528,"twenty":32.27459,"median":39.842867,"eighty":45.28245,"marketCap":4809688086},{"date":"2021-12-03","current":42.508177,"twenty":32.348817,"median":39.911012,"eighty":45.28245,"marketCap":4792286899},{"date":"2021-12-10","current":42.891493,"twenty":32.447032,"median":39.953188,"eighty":45.28245,"marketCap":4835501148},{"date":"2021-12-17","current":45.380751,"twenty":32.521786,"median":39.996581,"eighty":45.380751,"marketCap":5116135105},{"date":"2021-12-23","current":46.352906,"twenty":32.588031,"median":40.079057,"eighty":45.406143,"marketCap":5225733953},{"date":"2021-12-31","current":48.175698,"twenty":32.64443,"median":40.10618,"eighty":45.47788,"marketCap":5431231792},{"date":"2022-01-07","current":46.703962,"twenty":32.651599,"median":40.164071,"eighty":45.565296,"marketCap":5265311314},{"date":"2022-01-14","current":46.015352,"twenty":32.70478,"median":40.208708,"eighty":45.667046,"marketCap":5187678797},{"date":"2022-01-21","current":43.267663,"twenty":32.731462,"median":40.224323,"eighty":45.667046,"marketCap":4877909831},{"date":"2022-01-28","current":43.821252,"twenty":32.743358,"median":40.249944,"eighty":45.667046,"marketCap":4940320287},{"date":"2022-02-04","current":42.666817,"twenty":32.769192,"median":40.314701,"eighty":45.667046,"marketCap":4810171655},{"date":"2022-02-11","current":42.565551,"twenty":32.769192,"median":40.347561,"eighty":45.667046,"marketCap":4798755108},{"date":"2022-02-18","current":42.943612,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4841376882},{"date":"2022-02-25","current":37.784604,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4620036905},{"date":"2022-03-04","current":38.267307,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4679058463},{"date":"2022-03-11","current":37.29027,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4559593141},{"date":"2022-03-18","current":37.24956,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4554615419},{"date":"2022-03-25","current":38.110019,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4659826391},{"date":"2022-04-01","current":39.298046,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4805089927},{"date":"2022-04-08","current":39.763938,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4862056020},{"date":"2022-04-14","current":40.742313,"twenty":32.769192,"median":40.404479,"eighty":45.667046,"marketCap":4981684815},{"date":"2022-04-22","current":42.01187,"twenty":32.769192,"median":40.455317,"eighty":45.667046,"marketCap":5136917418},{"date":"2022-04-29","current":39.554287,"twenty":32.79826,"median":40.479695,"eighty":45.667046,"marketCap":4836421278},{"date":"2022-05-06","current":39.499614,"twenty":32.904642,"median":40.479695,"eighty":45.667046,"marketCap":5066773466},{"date":"2022-05-13","current":39.967203,"twenty":32.996397,"median":40.479695,"eighty":45.667046,"marketCap":5126753027},{"date":"2022-05-20","current":39.90291,"twenty":33.05702,"median":40.479695,"eighty":45.667046,"marketCap":5118505838},{"date":"2022-05-27","current":40.353768,"twenty":33.088236,"median":40.495181,"eighty":45.667046,"marketCap":5176339242},{"date":"2022-06-03","current":40.599257,"twenty":33.156377,"median":40.53176,"eighty":45.667046,"marketCap":5207829139},{"date":"2022-06-10","current":41.119461,"twenty":33.227354,"median":40.613635,"eighty":45.667046,"marketCap":5274557730},{"date":"2022-06-17","current":40.213488,"twenty":33.270165,"median":40.613635,"eighty":45.667046,"marketCap":5158345016},{"date":"2022-06-24","current":43.32302,"twenty":33.260026,"median":40.659236,"eighty":45.668114,"marketCap":5557217043},{"date":"2022-07-01","current":42.978166,"twenty":33.330747,"median":40.684242,"eighty":45.668114,"marketCap":5512981235},{"date":"2022-07-08","current":42.872956,"twenty":33.466784,"median":40.715658,"eighty":45.668114,"marketCap":5499485565},{"date":"2022-07-15","current":43.708789,"twenty":33.59929,"median":40.742313,"eighty":45.668114,"marketCap":5606701167},{"date":"2022-07-22","current":44.556311,"twenty":33.59929,"median":40.778643,"eighty":45.668114,"marketCap":5715416287},{"date":"2022-07-29","current":46.520226,"twenty":33.675236,"median":40.820493,"eighty":45.678143,"marketCap":5967335462},{"date":"2022-08-05","current":43.100932,"twenty":33.675236,"median":40.862996,"eighty":45.68777,"marketCap":6116022220},{"date":"2022-08-12","current":44.318758,"twenty":33.675236,"median":40.912721,"eighty":45.68777,"marketCap":6288831702},{"date":"2022-08-19","current":44.509569,"twenty":33.675236,"median":40.969109,"eighty":45.68777,"marketCap":6315907842},{"date":"2022-08-26","current":43.241234,"twenty":33.675236,"median":41.010201,"eighty":45.68777,"marketCap":6135931147},{"date":"2022-09-02","current":41.585665,"twenty":33.675236,"median":41.060268,"eighty":45.68777,"marketCap":5901005814},{"date":"2022-09-09","current":41.956063,"twenty":33.675236,"median":41.092655,"eighty":45.68777,"marketCap":5953565380},{"date":"2022-09-16","current":40.805583,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5790312183},{"date":"2022-09-23","current":39.935707,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5666876838},{"date":"2022-09-30","current":37.927001,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5381841428},{"date":"2022-10-07","current":36.428553,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5169211706},{"date":"2022-10-14","current":35.631626,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5056127734},{"date":"2022-10-21","current":36.636203,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5198677248},{"date":"2022-10-28","current":38.359137,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5443161610},{"date":"2022-11-04","current":41.724424,"twenty":33.675236,"median":41.119461,"eighty":45.68777,"marketCap":6035896875},{"date":"2022-11-11","current":42.347632,"twenty":33.675236,"median":41.160749,"eighty":45.68777,"marketCap":6126050848},{"date":"2022-11-18","current":42.756995,"twenty":33.675236,"median":41.197005,"eighty":45.68777,"marketCap":6185269635},{"date":"2022-11-25","current":43.056379,"twenty":33.675236,"median":41.218321,"eighty":45.68777,"marketCap":6228578896},{"date":"2022-12-02","current":43.196907,"twenty":33.675236,"median":41.257018,"eighty":45.68777,"marketCap":6248907733},{"date":"2022-12-09","current":43.795676,"twenty":33.675236,"median":41.35326,"eighty":45.68777,"marketCap":6335526256},{"date":"2022-12-16","current":43.172467,"twenty":33.675236,"median":41.423201,"eighty":45.68777,"marketCap":6245372283},{"date":"2022-12-23","current":43.685698,"twenty":33.675236,"median":41.463369,"eighty":45.68777,"marketCap":6319616732},{"date":"2022-12-30","current":43.337434,"twenty":33.675236,"median":41.483593,"eighty":45.68777,"marketCap":6269236570},{"date":"2023-01-06","current":43.245786,"twenty":34.167053,"median":41.539601,"eighty":45.68777,"marketCap":6255978633},{"date":"2023-01-13","current":45.714181,"twenty":34.992765,"median":41.587683,"eighty":45.704396,"marketCap":6613059075},{"date":"2023-01-20","current":45.402576,"twenty":35.880519,"median":41.605991,"eighty":45.714503,"marketCap":6567982088},{"date":"2023-01-27","current":45.378137,"twenty":36.169649,"median":41.646285,"eighty":45.714503,"marketCap":6564446638},{"date":"2023-02-03","current":45.255939,"twenty":36.592515,"median":41.674422,"eighty":45.714503,"marketCap":6546769389},{"date":"2023-02-10","current":44.406665,"twenty":36.713651,"median":41.711398,"eighty":45.714503,"marketCap":6423912504},{"date":"2023-02-17","current":44.157808,"twenty":36.89773,"median":41.739833,"eighty":45.714503,"marketCap":6731283715},{"date":"2023-02-24","current":42.410386,"twenty":36.963658,"median":41.754028,"eighty":45.714503,"marketCap":6464912060},{"date":"2023-03-03","current":41.690165,"twenty":37.214665,"median":41.783816,"eighty":45.714503,"marketCap":6355123742},{"date":"2023-03-10","current":39.423241,"twenty":37.286636,"median":41.783816,"eighty":45.714503,"marketCap":6009560514},{"date":"2023-03-17","current":40.355986,"twenty":37.342014,"median":41.783816,"eighty":45.714503,"marketCap":6151745384},{"date":"2023-03-24","current":39.606247,"twenty":37.466803,"median":41.783816,"eighty":45.714503,"marketCap":6037457546},{"date":"2023-03-31","current":40.621801,"twenty":37.536428,"median":41.78137,"eighty":45.714342,"marketCap":6192265465},{"date":"2023-04-06","current":39.692254,"twenty":37.577737,"median":41.783816,"eighty":45.714503,"marketCap":6050568092},{"date":"2023-04-14","current":39.289647,"twenty":37.687654,"median":41.784219,"eighty":45.714663,"marketCap":5989195981},{"date":"2023-04-21","current":39.792905,"twenty":37.872566,"median":41.784621,"eighty":45.714824,"marketCap":6065911119},{"date":"2023-04-28","current":40.118543,"twenty":37.943837,"median":41.797292,"eighty":45.714985,"marketCap":6115550327},{"date":"2023-05-05","current":39.964605,"twenty":38.110019,"median":41.797292,"eighty":45.714985,"marketCap":6092084520},{"date":"2023-05-12","current":39.104119,"twenty":38.249787,"median":41.797292,"eighty":45.714985,"marketCap":6176026400},{"date":"2023-05-19","current":38.898029,"twenty":38.342909,"median":41.797292,"eighty":45.714985,"marketCap":6143476946},{"date":"2023-05-26","current":37.796919,"twenty":38.456408,"median":41.797292,"eighty":45.714985,"marketCap":5969569863},{"date":"2023-06-02","current":37.832249,"twenty":38.456408,"median":41.797292,"eighty":45.714985,"marketCap":5975149770},{"date":"2023-06-09","current":38.668386,"twenty":38.476762,"median":41.797292,"eighty":45.714985,"marketCap":6107207554},{"date":"2023-06-16","current":38.786152,"twenty":38.533217,"median":41.797292,"eighty":45.714985,"marketCap":6125807242},{"date":"2023-06-23","current":38.509402,"twenty":38.553397,"median":41.809962,"eighty":45.718688,"marketCap":6082097976},{"date":"2023-06-30","current":38.55062,"twenty":38.5799,"median":41.81327,"eighty":45.72239,"marketCap":6088607866},{"date":"2023-07-07","current":38.662498,"twenty":38.628346,"median":41.81327,"eighty":45.72239,"marketCap":6106277570},{"date":"2023-07-14","current":38.603615,"twenty":38.628346,"median":41.81327,"eighty":45.72239,"marketCap":6096977726},{"date":"2023-07-21","current":39.357316,"twenty":38.659115,"median":41.81327,"eighty":45.72239,"marketCap":6216015729},{"date":"2023-07-28","current":39.404422,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6223455604},{"date":"2023-08-04","current":38.053978,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6196443469},{"date":"2023-08-11","current":37.511193,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6108060089},{"date":"2023-08-18","current":36.166029,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5889023018},{"date":"2023-08-25","current":36.531819,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5948585730},{"date":"2023-09-01","current":36.472821,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5938978841},{"date":"2023-09-08","current":35.75304,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5821774794},{"date":"2023-09-15","current":35.446248,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5771818971},{"date":"2023-09-22","current":33.711695,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5489376431},{"date":"2023-09-29","current":32.567126,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5303002783},{"date":"2023-10-06","current":32.649724,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5316452427},{"date":"2023-10-13","current":31.806046,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5179073913},{"date":"2023-10-20","current":32.41963,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5278985560},{"date":"2023-10-27","current":33.181375,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5472604212},{"date":"2023-11-03","current":35.377246,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5834769220},{"date":"2023-11-10","current":34.598655,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5706356142},{"date":"2023-11-17","current":35.425908,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5842795038},{"date":"2023-11-24","current":35.170433,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5800659496},{"date":"2023-12-01","current":36.015934,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5940108073},{"date":"2023-12-08","current":36.873602,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6081563104},{"date":"2023-12-15","current":37.7556,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6227031044},{"date":"2023-12-22","current":37.968496,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6262143995},{"date":"2023-12-29","current":38.607184,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":6367482847},{"date":"2024-01-05","current":38.296964,"twenty":38.756995,"median":41.871582,"eighty":45.73451,"marketCap":6316318262},{"date":"2024-01-12","current":38.090151,"twenty":38.758791,"median":41.871582,"eighty":45.73451,"marketCap":6282208538},{"date":"2024-01-19","current":36.989174,"twenty":38.764196,"median":41.872103,"eighty":45.735522,"marketCap":6100624420},{"date":"2024-01-26","current":36.295741,"twenty":38.758791,"median":41.871582,"eighty":45.73451,"marketCap":5986256523},{"date":"2024-02-02","current":37.232484,"twenty":38.697827,"median":41.871582,"eighty":45.73451,"marketCap":6140753507},{"date":"2024-02-09","current":35.261674,"twenty":38.661168,"median":41.871582,"eighty":45.73451,"marketCap":5815707904},{"date":"2024-02-16","current":33.847315,"twenty":38.629468,"median":41.871582,"eighty":45.73451,"marketCap":5752655855},{"date":"2024-02-23","current":33.670228,"twenty":38.597685,"median":41.871582,"eighty":45.73451,"marketCap":5722558249},{"date":"2024-03-01","current":32.436519,"twenty":38.556509,"median":41.871061,"eighty":45.733498,"marketCap":5512878257},{"date":"2024-03-08","current":33.758772,"twenty":38.535146,"median":41.871061,"eighty":45.733498,"marketCap":5737607052},{"date":"2024-03-15","current":32.6018,"twenty":38.489062,"median":41.871061,"eighty":45.733498,"marketCap":5540969356},{"date":"2024-03-22","current":33.262927,"twenty":38.456408,"median":41.871061,"eighty":45.733498,"marketCap":5653333754},{"date":"2024-03-28","current":33.457723,"twenty":38.385748,"median":41.784621,"eighty":45.733498,"marketCap":5686441121},{"date":"2024-04-05","current":33.192092,"twenty":38.338315,"median":41.766476,"eighty":45.73451,"marketCap":5641294711},{"date":"2024-04-12","current":33.499043,"twenty":38.271415,"median":41.746116,"eighty":45.73451,"marketCap":5693463896},{"date":"2024-04-19","current":32.99201,"twenty":38.226469,"median":41.73308,"eighty":45.73451,"marketCap":5607289064},{"date":"2024-04-26","current":33.647761,"twenty":38.150217,"median":41.720309,"eighty":45.733498,"marketCap":5827926731},{"date":"2024-05-03","current":33.618779,"twenty":38.090151,"median":41.711398,"eighty":45.733498,"marketCap":5822906984},{"date":"2024-05-10","current":34.482434,"twenty":38.029323,"median":41.69585,"eighty":45.733498,"marketCap":5972495456},{"date":"2024-05-17","current":34.986715,"twenty":37.950247,"median":41.66791,"eighty":45.733498,"marketCap":6059839061},{"date":"2024-05-24","current":34.198413,"twenty":37.871294,"median":41.619337,"eighty":45.733498,"marketCap":5923301932},{"date":"2024-05-31","current":34.928752,"twenty":37.820473,"median":41.602226,"eighty":45.733498,"marketCap":6049799566},{"date":"2024-06-07","current":35.908334,"twenty":37.7418,"median":41.585665,"eighty":45.733498,"marketCap":6219467028},{"date":"2024-06-14","current":35.311311,"twenty":37.642264,"median":41.478607,"eighty":45.73451,"marketCap":6116060232},{"date":"2024-06-21","current":35.485201,"twenty":37.563829,"median":41.447441,"eighty":45.735522,"marketCap":6146178716},{"date":"2024-06-28","current":35.734443,"twenty":37.537078,"median":41.447441,"eighty":45.738558,"marketCap":6189348544},{"date":"2024-07-05","current":35.879352,"twenty":37.482188,"median":41.447441,"eighty":45.738558,"marketCap":6214447281},{"date":"2024-07-12","current":36.957471,"twenty":37.418215,"median":41.439295,"eighty":45.738558,"marketCap":6401181884},{"date":"2024-07-15","current":37.189325,"twenty":37.412399,"median":41.439295,"eighty":45.738558,"marketCap":6441339863},{"date":"2024-08-02","current":37.993919,"twenty":37.339153,"median":41.40142,"eighty":45.707657,"marketCap":7107142493},{"date":"2024-08-09","current":38.417922,"twenty":37.339153,"median":41.351038,"eighty":45.669183,"marketCap":7186456557},{"date":"2024-08-16","current":38.455492,"twenty":37.339153,"median":41.248609,"eighty":45.587895,"marketCap":7193484385},{"date":"2024-08-23","current":38.879496,"twenty":37.339153,"median":41.197005,"eighty":45.51208,"marketCap":7272798449},{"date":"2024-08-30","current":39.104915,"twenty":37.339153,"median":41.152223,"eighty":45.432939,"marketCap":7314965420},{"date":"2024-09-06","current":40.19981,"twenty":37.339153,"median":41.109476,"eighty":45.406991,"marketCap":7519776420},{"date":"2024-09-13","current":40.725789,"twenty":37.339153,"median":41.060268,"eighty":45.379705,"marketCap":7618166018},{"date":"2024-09-20","current":39.786541,"twenty":37.339153,"median":41.020981,"eighty":45.296882,"marketCap":7442470307},{"date":"2024-09-27","current":39.931453,"twenty":37.339153,"median":40.992653,"eighty":45.271719,"marketCap":7469577645},{"date":"2024-10-04","current":40.355457,"twenty":37.339153,"median":40.937316,"eighty":45.211095,"marketCap":7548891709},{"date":"2024-10-11","current":39.3196,"twenty":37.339153,"median":40.894276,"eighty":45.159517,"marketCap":7355124439},{"date":"2024-10-18","current":40.731156,"twenty":37.339153,"median":40.838938,"eighty":45.089028,"marketCap":7619169993},{"date":"2024-10-25","current":42.532506,"twenty":37.339153,"median":40.820493,"eighty":45.046981,"marketCap":8077475775},{"date":"2024-10-31","current":40.816625,"twenty":37.339153,"median":40.816625,"eighty":44.988744,"marketCap":7751607762},{"date":"2024-11-08","current":40.076878,"twenty":37.338438,"median":40.773001,"eighty":44.942004,"marketCap":7611120201},{"date":"2024-11-15","current":41.115788,"twenty":37.338438,"median":40.773001,"eighty":44.942004,"marketCap":7808422584},{"date":"2024-11-22","current":41.948003,"twenty":37.338438,"median":40.773001,"eighty":44.914929,"marketCap":7966471090},{"date":"2024-11-29","current":41.773945,"twenty":37.338438,"median":40.773001,"eighty":44.914324,"marketCap":7933415193},{"date":"2024-12-06","current":40.849261,"twenty":37.338438,"median":40.770318,"eighty":44.892115,"marketCap":7757805742},{"date":"2024-12-13","current":40.055121,"twenty":37.338438,"median":40.736734,"eighty":44.892115,"marketCap":7606988214},{"date":"2024-12-20","current":37.770608,"twenty":37.338438,"median":40.680888,"eighty":44.892115,"marketCap":7173129570},{"date":"2024-12-27","current":38.515795,"twenty":37.338438,"median":40.640959,"eighty":44.892115,"marketCap":7314650128},{"date":"2025-01-03","current":37.933788,"twenty":37.338438,"median":40.614232,"eighty":44.892115,"marketCap":7204119473},{"date":"2025-01-10","current":37.906591,"twenty":37.337724,"median":40.580698,"eighty":44.89414,"marketCap":7198954490},{"date":"2025-01-17","current":39.244663,"twenty":37.333873,"median":40.538993,"eighty":44.89414,"marketCap":7453071695},{"date":"2025-01-24","current":38.87479,"twenty":37.333873,"median":40.501145,"eighty":44.89414,"marketCap":7382827915},{"date":"2025-01-31","current":39.761398,"twenty":37.333873,"median":40.465332,"eighty":44.84311,"marketCap":7551206388},{"date":"2025-02-07","current":39.74508,"twenty":37.333873,"median":40.424995,"eighty":44.718497,"marketCap":7548107398},{"date":"2025-02-14","current":40.634976,"twenty":37.333873,"median":40.403761,"eighty":44.67404,"marketCap":7688015540},{"date":"2025-02-21","current":40.363435,"twenty":37.333873,"median":40.374953,"eighty":44.653159,"marketCap":7636640801},{"date":"2025-02-28","current":41.687197,"twenty":37.333873,"median":40.374953,"eighty":44.559412,"marketCap":7887092651},{"date":"2025-03-07","current":42.394335,"twenty":37.33306,"median":40.37194,"eighty":44.562299,"marketCap":8020881032},{"date":"2025-03-14","current":42.767704,"twenty":37.33306,"median":40.383179,"eighty":44.562299,"marketCap":8091521298},{"date":"2025-03-21","current":43.141073,"twenty":37.417052,"median":40.40791,"eighty":44.562299,"marketCap":8162161563},{"date":"2025-03-28","current":42.993988,"twenty":37.479862,"median":40.452151,"eighty":44.562299,"marketCap":8134333580},{"date":"2025-04-04","current":43.440899,"twenty":37.536428,"median":40.487288,"eighty":44.562299,"marketCap":8218887836},{"date":"2025-04-11","current":41.268572,"twenty":37.537078,"median":40.501145,"eighty":44.559412,"marketCap":7807889929},{"date":"2025-04-17","current":44.145605,"twenty":37.540692,"median":40.519212,"eighty":44.559412,"marketCap":8352216066},{"date":"2025-04-25","current":43.782817,"twenty":37.571542,"median":40.572736,"eighty":44.653759,"marketCap":8377141546},{"date":"2025-05-02","current":45.953462,"twenty":37.571542,"median":40.583839,"eighty":44.677947,"marketCap":8792459672},{"date":"2025-05-09","current":43.031008,"twenty":37.571542,"median":40.598117,"eighty":44.677947,"marketCap":8233294969},{"date":"2025-05-16","current":42.422675,"twenty":37.571542,"median":40.624906,"eighty":44.677947,"marketCap":8116900028},{"date":"2025-05-23","current":42.755537,"twenty":37.571542,"median":40.666871,"eighty":44.677947,"marketCap":8180587826},{"date":"2025-05-30","current":42.698147,"twenty":37.571542,"median":40.666871,"eighty":44.677947,"marketCap":8169607171},{"date":"2025-06-06","current":42.411197,"twenty":37.571542,"median":40.666871,"eighty":44.666838,"marketCap":8114703897},{"date":"2025-06-13","current":42.927706,"twenty":37.571542,"median":40.666871,"eighty":44.666838,"marketCap":8213529790},{"date":"2025-06-20","current":43.220395,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":8269531129},{"date":"2025-06-27","current":41.894687,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":8015878004},{"date":"2025-07-03","current":41.30357,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":7902777259},{"date":"2025-07-11","current":40.735409,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":7794068777},{"date":"2025-07-18","current":41.234702,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":7889600473},{"date":"2025-07-25","current":42.319373,"twenty":37.604201,"median":40.725789,"eighty":44.606841,"marketCap":8097134849},{"date":"2025-08-01","current":42.372392,"twenty":37.604201,"median":40.742491,"eighty":44.606841,"marketCap":7873129491},{"date":"2025-08-08","current":43.918584,"twenty":37.604201,"median":40.752858,"eighty":44.633348,"marketCap":8160424292},{"date":"2025-08-15","current":42.901923,"twenty":37.604201,"median":40.790693,"eighty":44.633348,"marketCap":7971520467},{"date":"2025-08-22","current":44.019656,"twenty":37.604201,"median":40.820493,"eighty":44.633348,"marketCap":8179204204},{"date":"2025-08-29","current":43.199192,"twenty":37.604201,"median":40.894276,"eighty":44.633348,"marketCap":8026755504},{"date":"2025-09-05","current":42.806797,"twenty":37.595885,"median":40.935905,"eighty":44.639951,"marketCap":7953845256},{"date":"2025-09-12","current":43.841294,"twenty":37.604201,"median":40.969944,"eighty":44.633348,"marketCap":8146063183},{"date":"2025-09-19","current":42.527363,"twenty":37.604201,"median":41.008406,"eighty":44.633348,"marketCap":7901924321},{"date":"2025-09-26","current":41.962551,"twenty":37.639342,"median":41.035693,"eighty":44.633348,"marketCap":7796977752},{"date":"2025-10-03","current":42.027951,"twenty":37.639342,"median":41.102705,"eighty":44.633348,"marketCap":7809129460},{"date":"2025-10-10","current":41.974442,"twenty":37.639342,"median":41.115788,"eighty":44.633348,"marketCap":7799187153},{"date":"2025-10-17","current":44.322871,"twenty":37.639342,"median":41.17126,"eighty":44.633348,"marketCap":8235543942},{"date":"2025-10-24","current":44.544295,"twenty":37.639342,"median":41.220151,"eighty":44.656944,"marketCap":8621592904},{"date":"2025-10-31","current":43.1986,"twenty":37.639342,"median":41.2516,"eighty":44.656944,"marketCap":8361132219},{"date":"2025-11-07","current":42.991114,"twenty":37.639342,"median":41.30357,"eighty":44.656944,"marketCap":8320973082},{"date":"2025-11-14","current":43.690638,"twenty":37.639342,"median":41.35326,"eighty":44.656944,"marketCap":8456366743},{"date":"2025-11-21","current":43.68471,"twenty":37.639342,"median":41.452784,"eighty":44.656944,"marketCap":8455219339},{"date":"2025-11-28","current":44.591721,"twenty":37.639342,"median":41.521652,"eighty":44.656944,"marketCap":8630772135},{"date":"2025-12-05","current":44.093754,"twenty":37.639342,"median":41.583569,"eighty":44.656944,"marketCap":8534390208},{"date":"2025-12-12","current":42.244164,"twenty":37.639342,"median":41.619337,"eighty":44.656944,"marketCap":8176400191},{"date":"2025-12-19","current":42.902191,"twenty":37.639342,"median":41.692355,"eighty":44.656944,"marketCap":8303762024},{"date":"2025-12-26","current":42.919976,"twenty":37.639342,"median":41.746748,"eighty":44.656944,"marketCap":8307204236},{"date":"2026-01-02","current":42.700633,"twenty":37.639342,"median":41.754028,"eighty":44.656944,"marketCap":8264750291},{"date":"2026-01-09","current":41.977396,"twenty":37.639342,"median":41.778924,"eighty":44.654358,"marketCap":8124767015},{"date":"2026-01-16","current":42.688777,"twenty":37.639342,"median":41.778924,"eighty":44.603089,"marketCap":8262455483},{"date":"2026-01-23","current":42.700633,"twenty":37.639342,"median":41.778924,"eighty":44.565186,"marketCap":8264750291},{"date":"2026-01-30","current":42.659136,"twenty":37.639342,"median":41.778924,"eighty":44.544295,"marketCap":8256718464},{"date":"2026-02-06","current":45.131184,"twenty":37.639342,"median":41.778924,"eighty":44.513975,"marketCap":8735185890},{"date":"2026-02-13","current":44.908403,"twenty":37.639342,"median":41.778924,"eighty":44.506847,"marketCap":9176987197},{"date":"2026-02-20","current":45.230936,"twenty":37.639342,"median":41.778924,"eighty":44.513975,"marketCap":9242896611},{"date":"2026-02-27","current":46.784962,"twenty":37.639342,"median":41.778924,"eighty":44.52786,"marketCap":9560460154},{"date":"2026-03-06","current":47.517993,"twenty":37.639342,"median":41.778924,"eighty":44.544295,"marketCap":9710254277},{"date":"2026-03-13","current":46.714591,"twenty":37.639342,"median":41.778924,"eighty":44.544295,"marketCap":9546079918},{"date":"2026-03-20","current":46.13403,"twenty":37.639342,"median":41.778924,"eighty":44.544295,"marketCap":9427442972},{"date":"2026-03-27","current":43.629997,"twenty":37.639342,"median":41.778924,"eighty":44.513975,"marketCap":8915746245},{"date":"2026-04-02","current":44.474448,"twenty":37.639342,"median":41.778924,"eighty":44.463484,"marketCap":9088309076},{"date":"2026-04-10","current":45.752298,"twenty":37.639342,"median":41.778924,"eighty":44.447073,"marketCap":9349436265},{"date":"2026-04-17","current":46.315619,"twenty":37.639342,"median":41.778924,"eighty":44.447073,"marketCap":9464550524},{"date":"2026-04-24","current":42.221567,"twenty":37.639342,"median":41.778924,"eighty":44.388105,"marketCap":9263580602},{"date":"2026-05-01","current":42.145034,"twenty":37.639342,"median":41.773945,"eighty":44.310918,"marketCap":9246788997},{"date":"2026-05-08","current":41.718719,"twenty":37.639342,"median":41.749425,"eighty":44.205061,"marketCap":9153253847},{"date":"2026-05-15","current":41.144834,"twenty":37.639342,"median":41.735116,"eighty":44.170042,"marketCap":9027341145},{"date":"2026-05-22","current":41.363457,"twenty":37.639342,"median":41.708673,"eighty":44.159332,"marketCap":9075307889},{"date":"2026-05-29","current":40.745847,"twenty":37.635958,"median":41.645687,"eighty":44.142784,"marketCap":8939801838},{"date":"2026-06-05","current":39.477834,"twenty":37.639342,"median":41.613421,"eighty":44.076208,"marketCap":8661594725},{"date":"2026-06-12","current":40.871555,"twenty":37.639342,"median":41.561825,"eighty":44.020119,"marketCap":8967382716},{"date":"2026-06-18","current":40.341395,"twenty":37.639342,"median":41.522683,"eighty":43.960147,"marketCap":8851063362},{"date":"2026-06-26","current":41.527424,"twenty":37.635958,"median":41.458055,"eighty":43.866662,"marketCap":9111282946},{"date":"2026-07-02","current":41.691391,"twenty":37.635958,"median":41.455214,"eighty":43.838916,"marketCap":9147258004},{"date":"2026-07-10","current":42.549486,"twenty":37.635958,"median":41.455214,"eighty":43.812381,"marketCap":9335527473},{"date":"2026-07-17","current":44.134502,"twenty":37.635958,"median":41.455214,"eighty":43.800235,"marketCap":9683286364},{"date":"2026-07-24","current":43.620739,"twenty":37.635958,"median":41.455214,"eighty":43.790532,"marketCap":9570564516},{"date":"2026-07-31","current":43.306779,"twenty":37.632574,"median":41.452784,"eighty":43.772108,"marketCap":9737919027},{"date":"2026-08-07","current":42.169016,"twenty":37.632574,"median":41.452784,"eighty":43.730794,"marketCap":9482082868},{"date":"2026-08-14","current":41.48415,"twenty":37.632574,"median":41.412647,"eighty":43.686617,"marketCap":9328084404},{"date":"2026-08-21","current":41.119624,"twenty":37.632574,"median":41.35326,"eighty":43.679447,"marketCap":9246117479},{"date":"2026-08-28","current":40.429234,"twenty":37.632574,"median":41.30357,"eighty":43.643751,"marketCap":9090877092},{"date":"2026-09-04","current":40.169647,"twenty":37.632574,"median":41.279794,"eighty":43.619299,"marketCap":9032506706},{"date":"2026-09-11","current":39.48478,"twenty":37.632574,"median":41.2516,"eighty":43.588862,"marketCap":8878508241},{"date":"2026-09-18","current":37.645582,"twenty":37.632468,"median":41.211986,"eighty":43.520728,"marketCap":8464947849},{"date":"2026-09-25","current":37.104316,"twenty":37.487989,"median":41.17126,"eighty":43.502078,"marketCap":8343239385},{"date":"2026-10-02","current":35.916845,"twenty":37.413562,"median":41.155429,"eighty":43.482983,"marketCap":8076225919},{"date":"2026-10-08","current":35.988646,"twenty":37.342503,"median":41.115788,"eighty":43.476137,"marketCap":8092370919}],"updateTime":1791561791665},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADC\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659156389","title":"Press Release: Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156389","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156389?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:00","pubTimestamp":1786618800,"startTime":"0","endTime":"0","summary":"Phase 1 monotherapy study for 2L+ R/M HNSCC in Fall 2026. The update is. expected to include patients treated at 5.4 mg/kg IV Q3W with a dose. equivalent to or below a dose cap, together with detailed analyses of the. dose cap impact on safety, tolerability, efficacy and initial durability.-- The Company completed target enrollment in the Phase 1 Part 2. monotherapy dose expansion study in the first quarter of 2026.-- The ongoing MICVO Phase 1 monotherapy study is a multi-part study.Part 1 was a dose escalation study across multiple doses and tumor. types, with initial results shared in November 2024. Part 2, a. dose expansion study in 2L+ R/M HNSCC, is currently ongoing.Preliminary Phase 1 study results in 2L+ R/M HNSCC were shared in. December 2025, supporting MICVO's broad potential to address a. significant unmet need for patients regardless of HPV status or","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["L","R","BK4022","LU0210528500.USD","PYXS","NETL","BK4139","ADC","BK4232","BK4588","BK4080","LU2487616109.SGD","BK4231","BK4585","BK4107","LU0053666078.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659336901","title":"Agree Realty (ADC) Lifts Dividend As Income Narrative Keeps Valuation In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2659336901","media":"Simply Wall St.","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659336901?lang=en_us&edition=fundamental","pubTime":"2026-08-13 12:55","pubTimestamp":1786596926,"startTime":"0","endTime":"0","summary":"Agree Realty earnings and dividend move put income profile in focus\nAgree Realty (ADC) has given investors fresh information to work with after reporting second quarter 2026 results and announcing a higher monthly dividend alongside its latest earnings release.\nSee our latest analysis for Agree Realty.\nAt a share price of $74.36, Agree Realty has seen the 1-day share price return move up 1.32%, while the 30-day share price return is down 5.42%. Even so, the 1-year total shareholder return of...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-adc/agree-realty/news/agree-realty-adc-lifts-dividend-as-income-narrative-keeps-va","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-adc/agree-realty/news/agree-realty-adc-lifts-dividend-as-income-narrative-keeps-va","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ADC.AU","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121610795","title":"New Approval in China for Enhertu, a Key Antibody-Drug Conjugate from Daiichi Sankyo and AstraZeneca","url":"https://stock-news.laohu8.com/highlight/detail?id=1121610795","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121610795?lang=en_us&edition=fundamental","pubTime":"2026-08-13 07:28","pubTimestamp":1786577294,"startTime":"0","endTime":"0","summary":"A new indication for the antibody-drug conjugate (ADC) Enhertu, developed in collaboration between Daiichi Sankyo and AstraZeneca PLC (AZN.US), has secured approval for marketing in China as of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","LU2468319806.SGD","LU2237443382.USD","BK4585","BK4588","LU2089984988.USD","BK4231","LU0432979614.USD","BK4007","AZNH","LU0320765992.SGD","NETL","LU2237443549.SGD","LU0058720904.USD","BK4568","LU0889565916.HKD","LU2236285917.USD","ADC","LU1267930573.SGD","LU2237443895.HKD","LU1829250122.USD","LU2237443465.HKD","LU2417539215.USD","LU0289739699.SGD","AZN","LU2456880835.USD","BK4080","LU0310800379.SGD","IE00B3T34201.USD","LU2237443978.SGD","LU0029864427.USD","LU2237443622.USD","LU0109394709.USD","LU0708994859.HKD","LU2462157665.USD","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659074329","title":"Press Release: ArriVent BioPharma Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659074329","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659074329?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:01","pubTimestamp":1786564860,"startTime":"0","endTime":"0","summary":"-- Topline global pivotal Phase 3 data for firmonertinib in first-line EGFR. -- ARR-217, a CDH17 targeted ADC for gastrointestinal malignancies, advanced. -- Dosing of first patient with ARR-002, a dual-targeting MUC16/NaPi2b. tetravalent ADC with initial focus in ovarian and endometrial cancers. -- Cash and investments of $373.1 million as of June 30, 2026 expected to. Ongoing pivotal Phase 3 study in frontline EGFR exon 20 insertion mutant. NSCLC supported by preclinical data for EGFR inhibitor firmonertinib. showcased high resolution crystal structure data at the 2026 American. Association for Cancer Research  Annual Meeting.Pipeline-- Initiated Phase 1b Dose Optimization of ADC lead ARR-217 .ArriVent has initiated Phase 1b dose optimization for ARR-217, a CDH17. targeted ADC, in patients with gastrointestinal malignancies in. -- Clinically advancing ARR-002 in ovarian and endometrial cancer. ArriVent. the clinic through a first-in-human study evaluating safety, dosing, and. early s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","ADC","BK4231","LU0456854461.SGD","CRC","BK4139","AVBP","LU0266512127.USD","NETL","BK4080","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948757","title":"Agree Realty Umumkan Dividen Bulanan USD 0,27 Per Saham##","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948757","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948757?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:09","pubTimestamp":1786478975,"startTime":"0","endTime":"0","summary":"Agree Realty umumkan dividen bulanan USD 0,27 per saham##Agree Realty Corporation mendeklarasikan dividen tunai bulanan saham biasa sebesar $ 0,267 per saham.Dividen tersebut mencerminkan dividen tahu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL4vwb32:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NETL","BK4080","ADC","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658489529","title":"Agree Realty Declares Monthly Common and Preferred Dividends","url":"https://stock-news.laohu8.com/highlight/detail?id=2658489529","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658489529?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:05","pubTimestamp":1786478700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUA1CKMRT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4080","ADC","BK4231","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658394385","title":"Agree Realty Corporation - Declares Monthly Cash Dividend of $0.27 Per Common Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2658394385","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658394385?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:05","pubTimestamp":1786478700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nTUA1CKMRT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NETL","ADC","BK4231","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658998235","title":"Philips, Exor Agree to Raise Stakeholding Cap to 22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658998235","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658998235?lang=en_us&edition=fundamental","pubTime":"2026-08-11 16:08","pubTimestamp":1786435690,"startTime":"0","endTime":"0","summary":"Koninklijke Philips  and Exor said Tuesday they agreed to update their long-term relationship agreement, allowing Exor to increase its stake in Philips to up to 22% from the previous 20% cap.Exor could increase its stake further with approval from Philips' Supervisory Board, the companies said, adding that Governance arrangements remain unchanged, including Exor's right to nominate one member of the board.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PHG","BK4082","ADC","BK4585","BK4588","BK4080","NETL","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114647524","title":"BEONE MEDICINES Plans to Unveil Preliminary CEA ADC Findings for Non-Small Cell Lung Cancer, Including Both Squamous and Non-Squamous Cases","url":"https://stock-news.laohu8.com/highlight/detail?id=1114647524","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114647524?lang=en_us&edition=fundamental","pubTime":"2026-08-07 21:50","pubTimestamp":1786110636,"startTime":"0","endTime":"0","summary":"BEONE MEDICINES (06160.HK) announced during a research briefing that it intends to publish early-stage data on its CEA-targeting antibody-drug conjugate (ADC) for non-small cell lung cancer (NSCLC),...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0588546209.SGD","KURE","BK4526","NETL","LU1251922891.USD","BK1161","BK4139","LU1770034418.SGD","ONC","BK0239","06160","LU0307460666.USD","BK1588","688235","LU1719994722.HKD","BK4080","LU1969619763.USD","BK1500","LU2328871848.SGD","BK4231","BK1583","LU1303224171.USD","BK4588","BK4585","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657579126","title":"Press Release: OmniAb Reports Second Quarter 2026 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2657579126","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657579126?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:05","pubTimestamp":1786046700,"startTime":"0","endTime":"0","summary":"Raises Full Year 2026 Revenue and Cash Outlook Driven by Continued Business MomentumConference Call to Begin Today at 4:30 p.m. ETEMERYVILLE, Calif.--(BUSINESS WIRE)--August 06, 2026--OmniAb, Inc. (NA","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4022","ADC","BK4080","BK4232","BK4231","R","OABI","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657520016","title":"Press Release: NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2657520016","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657520016?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:01","pubTimestamp":1786046460,"startTime":"0","endTime":"0","summary":"-- Preserving Capital in Support of Merger Closing; Continuing Clinical. all-stock transaction. Upon closing, the combined company is expected to. operate as Avere Therapeutics and trade on Nasdaq under the ticker symbol. \"AVRX\". Existing NextCure stockholders are expected to receive contingent. value rights  tied to certain legacy NextCure assets.Concurrently, Avere Therapeutics entered into a securities purchase. agreement providing for a private financing expected to generate. approximately $320 million in gross proceeds immediately prior to closing. of the merger, subject to customary closing conditions.-- Entered into a Transition and Continuation Agreement with LigaChem. Biosciences  under which LigaChem has elected to continue the. development of LNCB74 as the \"Sole Developing Party\" pursuant to the. terms under the parties' November 2022 Research Collaboration and. remains eligible to receive future milestone and royalty payments for the. including facility footprint reductions","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTC","ADC","BK4139","NETL","BK4080","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657656921","title":"Whitehawk’s HWK-016 ADC Trial Advances in Tough Ovarian and Endometrial Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2657656921","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657656921?lang=en_us&edition=fundamental","pubTime":"2026-08-07 00:36","pubTimestamp":1786034167,"startTime":"0","endTime":"0","summary":"Whitehawk Therapeutics, Inc. ($WHWK) announced an update on their ongoing clinical study. Whitehawk Therapeutics, Inc. is running a Phase 1, first-...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/whitehawks-hwk-016-adc-trial-advances-in-tough-ovarian-and-endometrial-cancers?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/whitehawks-hwk-016-adc-trial-advances-in-tough-ovarian-and-endometrial-cancers?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADC","NETL","BK4080","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657659724","title":"Is Sichuan Kelun Biotech Biopharmaceutical (SEHK:6990) Cheap As ADC Pipeline News Builds?","url":"https://stock-news.laohu8.com/highlight/detail?id=2657659724","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657659724?lang=en_us&edition=fundamental","pubTime":"2026-08-06 21:37","pubTimestamp":1786023454,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) is back in focus after Chinese regulators accepted a new indication application for its TROP2-directed ADC sacituzumab tirumotecan in first-line triple-negative breast cancer.\nSee our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical.\nThe regulatory momentum around sacituzumab tirumotecan and SKB565 comes alongside a 26.81% year to date share price return and a very large 3 year total shareholder return of about 7x. This suggests...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/is-sichuan-kelun-biotech-biopharmaceutical-sehk6990-cheap-as","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6990/sichuan-kelun-biotech-biopharmaceutical-shares/news/is-sichuan-kelun-biotech-biopharmaceutical-sehk6990-cheap-as","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NETL","06990","BK4231","LU0196878994.USD","ADC","BK4581","BK1161","BK4585","BK4588","XBI","BK4080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657636277","title":"Press Release: Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2657636277","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657636277?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:00","pubTimestamp":1786017600,"startTime":"0","endTime":"0","summary":"financing. The financing included participation from existing investors. including Avoro Capital, QVT, Coastlands Capital, KVP Capital, ADAR1. Capital Management, Acuta Capital Partners, StemPoint Capital LP, Invus,as well as members of Whitehawk's executive team.-- Continued to enroll patients into ongoing Phase 1 trials for HWK-007 and. -- HWK--007 is being evaluated in patients with non-squamous, EGFR. cancer; and endometrial cancer . The study design was. presented as a Trials-in-Progress poster at the American Society. -- Entered into a new option agreement with Hangzhou DAC for access to. CPT113 for use in up to five additional ADC programs. Whitehawk's ADC. platform leverages CPT113 as the core linker-payload technology, adding. bioconjugation process to support improved stability and therapeutic","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WHWK","IND","BK4232","ADC","BK4231","BK4539","BK4139","R","NETL","LENZ","BK4022","BK4080","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657634536","title":"ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2657634536","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657634536?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:00","pubTimestamp":1786017600,"startTime":"0","endTime":"0","summary":"– On track for mid-2027 topline data readout from 80 patients in the Phase 2 ASPEN-09-Breast clinical trial evaluating evorpacept in combination with trastuzumab and chemotherapy in HER2-positive meta","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/06/3340196/0/en/ALX-Oncology-Reports-Second-Quarter-2026-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","BK4080","ADC","NETL","ALX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657687386","title":"Press Release: Zai Lab Announces Second Quarter 2026 Financial Results and Recent Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2657687386","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657687386?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:30","pubTimestamp":1786012200,"startTime":"0","endTime":"0","summary":"--  The Company advanced multiple global oncology and immunology programs. toward key clinical and regulatory milestones, with significant pipeline. --  Global Phase 1 data for zocilurtatug pelitecan  in combination. with a PD-L1 inhibitor in first-line SCLC to be presented at ESMO 2026;planned initiation of a registrational Phase 3 study later this year. --  Registrational Phase 3 DLLEVATE study evaluating zoci in second-line. plus SCLC remains on track, with enrollment expected to be completed in. the first half of 2027, supporting a potential U.S. accelerated approval. --  Global Phase 1/1b study of ZL-1503, a potential first-in-class. long-acting IL-13/IL-31R<ALPHA> bispecific antibody for the treatment of. atopic dermatitis, continues to advance, with initial first-in-human data. --  KarXT successfully launched in mainland China; encouraging early launch. trends building momentum ahead of potential NRDL inclusion. --  Total revenues of $106.3 million in the second quarter of 2026;","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","BK4081","BK4531","BK4022","BK4548","IE0009354923.USD","ODD","NETL","ADC","BK4231","BK4139","BK4588","BK4526","IND","BK4232","ZLAB","EMA","BK4183","BK4585","BK4080","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182119210","title":"Hong Kong Stock Moves: SKB BIO Surges Over 4% Before Noon as New Dual-Load ADC Drug Gets Clinical Trial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1182119210","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182119210?lang=en_us&edition=fundamental","pubTime":"2026-08-06 11:22","pubTimestamp":1785986533,"startTime":"0","endTime":"0","summary":"SKB BIO (06990) climbed more than 4% before the midday trading session, with shares last up 3.8% to HK$510.5, on turnover of HK$95.924 million.The company recently announced that it has received a...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IBBJ","BK4231","PSYK","BK4585","BMED","MDTX","LU0196878994.USD","BK4080","ADC","NETL","VXUS","IBBQ","KCAI","06990","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657560199","title":"Agree Realty Releases Transcript of Q2 2026 Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2657560199","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657560199?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:53","pubTimestamp":1785880434,"startTime":"0","endTime":"0","summary":"Agree Realty releases transcript of Q2 2026 earnings callAgree Realty discussed second-quarter 2026 results on a July 31 earnings call attended by senior management and analysts from UBS, Citi, Wells ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL2gCp6d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1548497426.USD","LU2357305700.SGD","TFNS","IAI","BK4207","LU2028103732.USD","LU1244550577.SGD","IYF","BK4127","LU0052756011.USD","LU1732800096.USD","LU0528227936.USD","LU0320765646.SGD","LU0128525689.USD","KBWB","LU0882574139.USD","LU1244550221.USD","LU1363072403.SGD","LU2264538146.SGD","BK4581","LU0980610538.SGD","LU2456880835.USD","LU1074936037.SGD","LU2360032135.SGD","LU0795875086.SGD","LU2023251221.USD","FTXO","NETL","LU2417539215.USD","LU0234570918.USD","ADC","LU1267930227.SGD","EVR","LU2462157665.USD","IE00B775SV38.USD","EVRDD","LU0210528500.USD","BK4504","LU2271345857.HKD","IE00BKVL7J92.USD","LU2347655156.SGD","LU0203345920.USD","LU0130102774.USD","LU0225283273.USD","LU0162691827.USD","BK4588","LU0106831901.USD","LU2487616109.SGD","LU1989772840.SGD","BK4585","LU0971096721.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656545055","title":"Akari Therapeutics Releases CEO Corner Highlighting Strategic WhiteHawk Collaboration and the Expanding Opportunity for Dual-Payload ADC Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2656545055","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656545055?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:50","pubTimestamp":1785847800,"startTime":"0","endTime":"0","summary":"Discussion explores how combining complementary payload technologies may unlock new therapeutic opportunities while reinforcing the versatility of Akari's proprietary PH1 spliceosome-modulating payloa","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/04/3338337/0/en/Akari-Therapeutics-Releases-CEO-Corner-Highlighting-Strategic-WhiteHawk-Collaboration-and-the-Expanding-Opportunity-for-Dual-Payload-ADC-Innovation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","LENZ","ADC","BK4007","BK4080","BK4231","NETL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656531754","title":"Yomiuri: Japan, Mexico Agree to Expand Bilateral Cooperation on Economic Security, Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2656531754","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656531754?lang=en_us&edition=fundamental","pubTime":"2026-08-04 17:54","pubTimestamp":1785837240,"startTime":"0","endTime":"0","summary":"Yomiuri Shimbun Staff WriterJapanese Foreign Minister Toshimitsu Motegi agreed with his Mexican counterpart Roberto Velasco to reinforce bilateral cooperation in such fields as economic security, energy, science and technology, at a meeting held on Monday in Mexico City.During telephone talks between Japanese Prime Minister Sanae Takaichi and Mexican President Claudia Sheinbaum in April, both sides agreed that Japan would import 1 million barrels of Mexican crude oil in response to the Middle East conflict. The agreement was carried out by July, according to the Japanese Foreign Ministry.At Monday's meeting, Motegi and Velasco agreed to continue and strengthen cooperation in the energy sector and confirmed that they would hold their first meeting on economic security by the end of March 2027.The administration of U.S. President Donald Trump has refused to extend the North American trade pact -- the United States-Mexico-Canada Agreement  -- in its current form. Motegi and Velasco agreed","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","BK4231","NETL","BK4080"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}